133 related articles for article (PubMed ID: 32372739)
1. The association of clozapine and haematological malignancies needs to be replicated by other studies and more importantly by analyses of subsamples from VigiBase.
de Leon J; De Las Cuevas C; Sanz EJ; Verdoux H
Psychol Med; 2021 Jun; 51(8):1405-1406. PubMed ID: 32372739
[No Abstract] [Full Text] [Related]
2. Response to 'The association of clozapine and haematological malignancies needs to be replicated by other studies and more importantly by analyses of subsamples from VigiBase'.
Chrétien B; Lelong-Boulouard V; Alexandre J; Fedrizzi S; Dolladille C
Psychol Med; 2021 Jun; 51(8):1407-1408. PubMed ID: 32635951
[No Abstract] [Full Text] [Related]
3. Haematologic malignancies associated with clozapine
Chrétien B; Lelong-Boulouard V; Chantepie S; Sassier M; Bertho M; Brazo P; Humbert X; Alexandre J; Fedrizzi S; Dolladille C
Psychol Med; 2021 Jul; 51(9):1459-1466. PubMed ID: 32036793
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
[TBL] [Abstract][Full Text] [Related]
5. Association between myocarditis and antipsychotics other than clozapine: a systematic literature review and a pharmacovigilance study using VigiBase.
De Las Cuevas C; Sanz EJ; Rohde C; de Leon J
Expert Rev Clin Pharmacol; 2022 Jan; 15(1):65-78. PubMed ID: 35062840
[TBL] [Abstract][Full Text] [Related]
6. Clozapine and the risk of haematological malignancies.
Schulte PF; Cohen D; Veerman SR; Bakker B; Bogers JP
Lancet Psychiatry; 2022 Jul; 9(7):538-539. PubMed ID: 35717957
[No Abstract] [Full Text] [Related]
7. Clozapine and the risk of haematological malignancies.
de Leon J; De Las Cuevas C; Sanz EJ; Ruan CJ; Correll CU
Lancet Psychiatry; 2022 Jul; 9(7):537-538. PubMed ID: 35717956
[No Abstract] [Full Text] [Related]
8. Clozapine and the risk of haematological malignancies - Authors' reply.
Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Lancet Psychiatry; 2022 Jul; 9(7):539-540. PubMed ID: 35717958
[No Abstract] [Full Text] [Related]
9. Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countries.
De Las Cuevas C; Sanz EJ; Ruan CJ; de Leon J
Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(4):238-250. PubMed ID: 36513400
[TBL] [Abstract][Full Text] [Related]
10. Safety of clozapine use during pregnancy: Analysis of international pharmacovigilance data.
Beex-Oosterhuis MM; Samb A; Heerdink ER; Souverein PC; Van Gool AR; Meyboom RHB; van Marum RJ
Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):725-735. PubMed ID: 32378285
[TBL] [Abstract][Full Text] [Related]
11. Haematological side effects associated with clozapine: A retrospective study from India.
Grover S; Shouan A; Chakrabarti S; Avasthi A
Asian J Psychiatr; 2020 Feb; 48():101906. PubMed ID: 31865196
[TBL] [Abstract][Full Text] [Related]
12. Evolving prevalence of haematological malignancies in orphan designation procedures in the European Union.
Polsinelli B; Tsigkos S; Naumann-Winter F; Mariz S; Sepodes B
Orphanet J Rare Dis; 2017 Jan; 12(1):17. PubMed ID: 28109318
[TBL] [Abstract][Full Text] [Related]
13. The potential role of Aurora kinase inhibitors in haematological malignancies.
Farag SS
Br J Haematol; 2011 Dec; 155(5):561-79. PubMed ID: 21980926
[TBL] [Abstract][Full Text] [Related]
14. PI3K as a target for therapy in haematological malignancies.
Khwaja A
Curr Top Microbiol Immunol; 2010; 347():169-88. PubMed ID: 20517718
[TBL] [Abstract][Full Text] [Related]
15. [Incidence of haematological malignancies in adults in Szabolcs-Szatmár-Bereg county, Hungary, between 1983 and 2012. Analysis of data from a thirty-year period].
Jakó J; Szerafin L; Nagy P
Orv Hetil; 2013 Nov; 154(47):1858-64. PubMed ID: 24240522
[TBL] [Abstract][Full Text] [Related]
16. Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies.
Teachey DT; Grupp SA; Brown VI
Br J Haematol; 2009 Jun; 145(5):569-80. PubMed ID: 19344392
[TBL] [Abstract][Full Text] [Related]
17. Haematological toxicity of clozapine and some other drugs used in psychiatry.
Nooijen PM; Carvalho F; Flanagan RJ
Hum Psychopharmacol; 2011 Mar; 26(2):112-9. PubMed ID: 21416507
[TBL] [Abstract][Full Text] [Related]
18. [Intensive pharmacovigilance of clozapine in Argentina].
Balda MV; Daray FM
Vertex; 2015; 26(122):292-301. PubMed ID: 26672506
[TBL] [Abstract][Full Text] [Related]
19. m-TOR inhibitors and their potential role in haematological malignancies.
Calimeri T; Ferreri AJM
Br J Haematol; 2017 Jun; 177(5):684-702. PubMed ID: 28146265
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis.
Dagnew AF; Ilhan O; Lee WS; Woszczyk D; Kwak JY; Bowcock S; Sohn SK; Rodriguez Macías G; Chiou TJ; Quiel D; Aoun M; Navarro Matilla MB; de la Serna J; Milliken S; Murphy J; McNeil SA; Salaun B; Di Paolo E; Campora L; López-Fauqued M; El Idrissi M; Schuind A; Heineman TC; Van den Steen P; Oostvogels L;
Lancet Infect Dis; 2019 Sep; 19(9):988-1000. PubMed ID: 31399377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
